Searched over 200M research papers
6 papers analyzed
These studies suggest that rosuvastatin calcium is a specific form of rosuvastatin used in various pharmaceutical preparations and quality control methods, with its bioavailability and concentration influenced by formulation and external factors.
20 papers analyzed
Rosuvastatin is a widely used medication belonging to the class of drugs known as statins, which are primarily prescribed to lower cholesterol levels and reduce the risk of cardiovascular diseases. Rosuvastatin calcium is the calcium salt form of rosuvastatin, which is the active ingredient in many cholesterol-lowering medications.
Rosuvastatin calcium is chemically defined as bis [(E)-7-[4-(4-fluorophenyl)-6-isopropyl-2[methyl (methyl sulfonyl) amino] pyrimidin-5-yl] (3R, 5S)-3, 5-dihydroxy hept-6-enoic acid] calcium salt. This compound functions as a selective and competitive inhibitor of the enzyme 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, which plays a crucial role in the biosynthesis of cholesterol in the liver.
Rosuvastatin is often formulated as rosuvastatin calcium in various pharmaceutical products. The calcium salt form enhances the stability and solubility of the drug, making it more effective for oral administration. Studies have shown that formulations of rosuvastatin calcium, such as self nanoemulsifying drug delivery systems (SNEDDS), significantly improve the solubility and bioavailability of the drug compared to traditional formulations. This enhanced bioavailability is crucial for achieving the desired therapeutic effects at lower doses.
The quality attributes of rosuvastatin calcium tablets, including weight variation, disintegration time, and drug content, are critical for ensuring consistent therapeutic outcomes. Research comparing various generic brands of rosuvastatin calcium tablets has revealed that while most generics meet pharmacopeial standards, some fail to achieve in vitro bioequivalence with the proprietary brand, indicating variability in drug release profiles. This underscores the importance of rigorous quality control in the manufacturing of rosuvastatin calcium tablets.
Several analytical methods have been developed for the determination of rosuvastatin calcium in pharmaceutical formulations and biological fluids. These methods include spectrophotometry, high-performance liquid chromatography (HPLC), and tandem mass spectrometry (LC-MS/MS). These techniques are essential for ensuring the accuracy and precision of drug content in various formulations, thereby guaranteeing the efficacy and safety of the medication.
Rosuvastatin calcium is often co-formulated with other drugs, such as fenofibrate and aspirin, to enhance its therapeutic effects. For instance, co-formulation with fenofibrate is used for the treatment of hyperlipidemia, and analytical methods have been developed to simultaneously estimate the concentrations of both drugs in combined formulations . These co-formulations offer the advantage of combined therapeutic effects, potentially improving patient compliance and outcomes.
In summary, rosuvastatin and rosuvastatin calcium are closely related, with the latter being the calcium salt form used in pharmaceutical formulations to enhance stability and bioavailability. The effectiveness of rosuvastatin calcium in lowering cholesterol and reducing cardiovascular risk is well-documented, and its quality and bioequivalence are critical for ensuring consistent therapeutic outcomes. Advanced analytical methods play a vital role in the accurate determination of rosuvastatin calcium in various formulations, supporting its safe and effective use in clinical practice.
Most relevant research papers on this topic